Variant report
| Variant | rs73937264 |
|---|---|
| Chromosome Location | chr2:63926874-63926875 |
| allele | C/T |
| Outlinks | Ensembl UCSC |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr2:63923800-63927200 | Enhancers | Liver | Liver |
| 2 | chr2:63925400-63927000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
| 3 | chr2:63925400-63927200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
| 4 | chr2:63925400-63927200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
| 5 | chr2:63925400-63927200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
| 6 | chr2:63925400-63927200 | Enhancers | HMEC | breast |
| 7 | chr2:63925400-63927200 | Enhancers | HUVEC | blood vessel |
| 8 | chr2:63925400-63927800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 9 | chr2:63925600-63927200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
| 10 | chr2:63925600-63927200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
| 11 | chr2:63925800-63927000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
| 12 | chr2:63925800-63927000 | Flanking Active TSS | A549 | lung |
| 13 | chr2:63925800-63927200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
| 14 | chr2:63925800-63927200 | Enhancers | HSMMtube | muscle |
| 15 | chr2:63926000-63927000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 16 | chr2:63926400-63927000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
| 17 | chr2:63926400-63927000 | Enhancers | Hela-S3 | cervix |
| 18 | chr2:63926400-63927200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
| 19 | chr2:63926400-63927200 | Enhancers | HSMM | muscle |
| 20 | chr2:63926400-63927200 | Enhancers | NHEK | skin |
| 21 | chr2:63926400-63927400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 22 | chr2:63926400-63927600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
| 23 | chr2:63926400-63935400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
| 24 | chr2:63926600-63927000 | Weak transcription | Psoas Muscle | Psoas |
| 25 | chr2:63926600-63927000 | Enhancers | HepG2 | liver |
| 26 | chr2:63926600-63927200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
| 27 | chr2:63926600-63927200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
| 28 | chr2:63926600-63927200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
| 29 | chr2:63926600-63927200 | Enhancers | Osteobl | bone |
| 30 | chr2:63926800-63927000 | Flanking Active TSS | NHDF-Ad | bronchial |
| 31 | chr2:63926800-63927400 | Enhancers | Muscle Satellite Cultured Cells | -- |
| 32 | chr2:63926800-63939800 | Weak transcription | Adipose Nuclei | Adipose |
| 33 | chr2:63926800-63956600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
